Search

everythinglearnresearchcommunity

for

Search:↓

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

Hepatitis C virus can cause skin diseases and dermatologists play a crucial role in identifying these conditions.

Satoyoshi syndrome is likely an autoimmune disease.

Frontal Fibrosing Alopecia might be an autoimmune disease.

Enhancing regulatory T cells may help treat autoimmune diseases like alopecia areata.

The document suggests there might be a link between Kawasaki Disease and Alopecia Areata that needs more research.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

Skin stem cells remember past inflammation, helping them respond better to future injuries and possibly aiding in treating skin issues.

Diet can influence inflammatory skin diseases.

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

Granzyme B is important in autoimmune skin diseases and could be a new treatment target.

EMT plays a key role in skin fibrosis and offers new therapy targets.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Eph/ephrin signaling is important for skin cell behavior and could be targeted to treat skin diseases.

Exosomes could revolutionize skin disease treatment and healing.

Frontal Fibrosing Alopecia is a poorly understood condition that is hard to treat and causes distressing hair loss.

Common gene patterns may cause skin autoimmune diseases.

The model helps understand alopecia areata and suggests ways to improve treatment by targeting immune issues.

Many patients experienced hair loss after COVID-19, with women affected more, starting on average 49 days post-infection.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Total glucosides of paeony can help treat skin conditions but need more research for clinical use.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Alopecia areata may protect against graft dysfunction, while asthma may increase its risk.

BTNL proteins help control inflammatory bowel disease by maintaining specific immune cells.

Skin diseases like acne and psoriasis are linked to stress, gut health, and inflammation, with new treatments focusing on gut and mind-body approaches.

More precise, personalized therapies are needed for autoimmune diseases.

NK cells play a role in skin diseases like eczema and psoriasis.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

Anti-complement agents could effectively treat autoimmune diseases with fewer side effects.